The overexpression of miR-340-5p inhibits IL-1β and IL-6, which in turn inhibits the inflammation, cell proliferation, and migration of PASMCs, thereby inhibiting thrombosis and APE-induced PAH. The gene discussed is IL1B; the disease is pulmonary arterial hypertension.